Centrum Kardiometaboliczne Gierach-Med Marcin Gierach
- Address
- Ul. Bydgoskich Olimpijczykow 5/39-40, 85-796 Bydgoszcz, Poland
Centrum Kardiometaboliczne Gierach-Med Marcin Gierach
Centrum Kardiometaboliczne Gierach-Med Marcin Gierach is a specialized medical research facility dedicated to advancing clinical knowledge in cardiometabolic health. The center focuses on investigating innovative therapeutic approaches for conditions affecting both cardiovascular and metabolic systems, with particular emphasis on weight management and metabolic disorders.
- Overweight and obesity management interventions
- Novel pharmacological approaches for weight reduction
- Cardiometabolic disease prevention and treatment
The center conducts rigorous clinical trials evaluating weight reduction therapies as adjuncts to lifestyle modifications including reduced-calorie diet and increased physical activity. Their research contributes to establishing evidence-based treatment protocols for patients with overweight and obesity, addressing the growing public health challenge of metabolic syndrome and its associated cardiovascular complications.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Novo Nordisk A/S1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novo Nordisk A/S4trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrum Kardiometaboliczne Gierach-Med Marcin Gierach
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Cardiovascular Safety of Cagrilintide and Semaglutide in Participants with Established Cardiovascular Disease | Novo Nordisk A/S | Phase III | Not Recruiting | Feb 2023 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cagrilintide | 3 | Unknown | 2023-01-30 | 2026-07-27 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.